Talphera, Inc.

NasdaqGM:TLPH Stock Report

Market Cap: US$9.0m

Talphera Management

Management criteria checks 3/4

Talphera's CEO is Vince Angotti, appointed in Mar 2017, has a tenure of 7.75 years. total yearly compensation is $1.21M, comprised of 54.1% salary and 45.9% bonuses, including company stock and options. directly owns 0.76% of the company’s shares, worth $68.85K. The average tenure of the management team and the board of directors is 7.5 years and 7.8 years respectively.

Key information

Vince Angotti

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage54.1%
CEO tenure7.8yrs
CEO ownership0.8%
Management average tenure7.5yrs
Board average tenure7.8yrs

Recent management updates

Recent updates

AcelRx: The Catalogue Of Catalysts - Including A Big One That Will Do Investors Well

Aug 18

AcelRx Pharmaceuticals: Finally, Plan B

Jun 06

AcelRx Pharmaceuticals: Making Sense Of The Q4 Numbers

Mar 16

AcelRx Pharmaceuticals: The Fog Is Getting Thicker

Jan 14

AcelRx: Battered And Bruised But Ready For Recovery In 2022

Jan 05

AcelRx Pharmaceuticals: Is Wayne Gretzky Right Or The Puck?

Oct 02

AcelRx Pharmaceuticals: How The Licensing Agreements Could Become A Shot In The Arm

Jul 27

FDA agrees with AcelRx to update promotional materials for Dsuvia

Jun 17

Shareholders May Find It Hard To Justify Increasing AcelRx Pharmaceuticals, Inc.'s (NASDAQ:ACRX) CEO Compensation For Now

Jun 11
Shareholders May Find It Hard To Justify Increasing AcelRx Pharmaceuticals, Inc.'s (NASDAQ:ACRX) CEO Compensation For Now

AcelRx Pharmaceuticals: A Bullish View In 3 Song Titles

May 31

CEO Compensation Analysis

How has Vince Angotti's remuneration changed compared to Talphera's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$16m

Jun 30 2024n/an/a

-US$14m

Mar 31 2024n/an/a

-US$14m

Dec 31 2023US$1mUS$656k

-US$10m

Sep 30 2023n/an/a

-US$11m

Jun 30 2023n/an/a

-US$14m

Mar 31 2023n/an/a

US$58m

Dec 31 2022US$1mUS$637k

US$54m

Sep 30 2022n/an/a

US$69m

Jun 30 2022n/an/a

US$65m

Mar 31 2022n/an/a

-US$31m

Dec 31 2021US$2mUS$637k

-US$17m

Sep 30 2021n/an/a

-US$36m

Jun 30 2021n/an/a

-US$37m

Mar 31 2021n/an/a

-US$33m

Dec 31 2020US$2mUS$637k

-US$40m

Sep 30 2020n/an/a

-US$46m

Jun 30 2020n/an/a

-US$50m

Mar 31 2020n/an/a

-US$55m

Dec 31 2019US$2mUS$618k

-US$53m

Sep 30 2019n/an/a

-US$51m

Jun 30 2019n/an/a

-US$51m

Mar 31 2019n/an/a

-US$49m

Dec 31 2018US$2mUS$600k

-US$47m

Sep 30 2018n/an/a

-US$44m

Jun 30 2018n/an/a

-US$45m

Mar 31 2018n/an/a

-US$48m

Dec 31 2017US$2mUS$493k

-US$52m

Compensation vs Market: Vince's total compensation ($USD1.21M) is above average for companies of similar size in the US market ($USD646.54K).

Compensation vs Earnings: Vince's compensation has been consistent with company performance over the past year.

CEO

Vince Angotti (56 yo)

7.8yrs

Tenure

US$1,211,994

Compensation

Mr. Vincent J. Angotti, also known as Vince, has been the Chief Executive Officer of Talphera, Inc. (formerly known as AcelRx Pharmaceuticals, Inc.) since March 6, 2017. Mr. Angotti served as the Chief Exe...

Leadership Team

NamePositionTenureCompensationOwnership
Vincent Angotti
CEO & Director7.8yrsUS$1.21m0.76%
$ 68.8k
Raffi Asadorian
Chief Financial Officer7.3yrsUS$742.61k0.080%
$ 7.3k
Anil Dasu
Chief Engineering Officer17.3yrsUS$686.35k0.070%
$ 6.3k
Shakil Aslam
Chief Medical Officerless than a yearno datano data

7.5yrs

Average Tenure

56yo

Average Age

Experienced Management: TLPH's management team is seasoned and experienced (7.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Vincent Angotti
CEO & Director7.8yrsUS$1.21m0.76%
$ 68.8k
Mark Allen Wan
Independent Director18.3yrsUS$69.79k0.011%
$ 973.8
Stephen Hoffman
Independent Director14.8yrsUS$47.29k0.011%
$ 973.8
William Schmidt
Member of Medical Advisory Boardno datano datano data
Adrian Adams
Independent Chairman11.8yrsUS$104.79k0.062%
$ 5.6k
Marina Bozilenko
Independent Director3.8yrsUS$62.29k0.010%
$ 940.5
Jill Broadfoot
Independent Director3.1yrsUS$62.29k0.0075%
$ 675.1
Eugene Viscusi
Member of Medical Advisory Boardno datano datano data
Jonathan Schaffer
Member of Medical Advisory Boardno datano datano data
Mary Southam
Member of Medical Advisory Boardno datano datano data
Katsuto Shinohara
Member of Medical Advisory Boardno datano datano data
Abhinav Jain
Independent Directorless than a yearno datano data

7.8yrs

Average Tenure

60.5yo

Average Age

Experienced Board: TLPH's board of directors are considered experienced (7.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 08:38
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Talphera, Inc. is covered by 19 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
David BuckB. Riley Securities, Inc.
Andrew D'SilvaB. Riley Securities, Inc.